Pulmonary pharmacokinetics of tulathromycin in swine. Part 2: Intra-airways compartments. - Wikidata - awgldk - TriplyDB

Pulmonary pharmacokinetics of tulathromycin in swine. Part 2: Intra-airways compartments.

Pulmonary pharmacokinetics of tulathromycin in swine. Part 2: Intra-airways compartments.

http://www.wikidata.org/entity/Q46490969

about

Comparison of Active Drug Concentrations in the Pulmonary Epithelial Lining Fluid and Interstitial Fluid of Calves Injected with Enrofloxacin, Florfenicol, Ceftiofur, or Tulathromycin The Epidemiologic and Pharmacodynamic Cutoff Values of Tilmicosin against Haemophilus parasuis Understanding the pharmacokinetics of tulathromycin: a pulmonary perspective.Pharmacokinetics and pharmacodynamics of gamithromycin in pulmonary epithelial lining fluid in naturally occurring bovine respiratory disease in multisource commingled feedlot cattle.Standard PK/PD concepts can be applied to determine a dosage regimen for a macrolide: the case of tulathromycin in the calf.The influence of Actinobacillus pleuropneumoniae infection on tulathromycin pharmacokinetics and lung tissue disposition in pigs.Pharmacokinetics of tulathromycin in edible tissues of healthy and experimentally infected pigs with Actinobacillus pleuropneumoniae.Pulmonary pharmacokinetics of tulathromycin in swine. Part I: Lung homogenate in healthy pigs and pigs challenged intratracheally with lipopolysaccharide of Escherichia coli.PK-PD Analysis of Marbofloxacin against Streptococcus suis in Pigs.PK-PD Integration Modeling and Cutoff Value of Florfenicol against Streptococcus suis in Pigs.The pharmacokinetic-pharmacodynamic modeling and cut-off values of tildipirosin against Haemophilus parasuis.Pharmacokinetics of tildipirosin in pig tonsils.

P2860

Q27322047-F62F0220-F318-4A95-AC6D-63B63CE11279 Q36713673-2D284E32-7568-4006-A0A3-784EB6F52326 Q38151858-56B5CA55-87CF-45F1-ABE6-F7755F45CAA2 Q40461646-2D3AA9A6-1D3F-4030-A0E2-C3256F64C6C7 Q40584376-60FF1748-23D9-41EE-89B8-AD594DE2F2B1 Q41054410-22B2696B-2F69-4F70-9DFF-56C749D3592B Q41069309-8E0FE29F-9264-45FD-96E0-90F3F18CC637 Q43917247-C1639FA7-0806-414F-9C15-91FFE4761238 Q47362352-54C140FD-D242-4EDC-AF0D-AC1D08965EA3 Q47701094-3B316168-4BEE-4B24-9CD7-5EE227A3B806 Q49210057-F6AFADB6-1037-48AC-89DC-C6C4100F5830 Q53160948-3070314D-56DA-4C74-914F-0BCAFAE0B2F4

P2860

Pulmonary pharmacokinetics of tulathromycin in swine. Part 2: Intra-airways compartments.

http://www.wikidata.org/entity/Q46490969

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Pulmonary pharmacokinetics of tulathromycin in swine. Part 2: Intra-airways compartments.

@en

Pulmonary pharmacokinetics of tulathromycin in swine. Part 2: Intra-airways compartments.

@nl

type

label

Pulmonary pharmacokinetics of tulathromycin in swine. Part 2: Intra-airways compartments.

@en

Pulmonary pharmacokinetics of tulathromycin in swine. Part 2: Intra-airways compartments.

@nl

prefLabel

Pulmonary pharmacokinetics of tulathromycin in swine. Part 2: Intra-airways compartments.

@en

Pulmonary pharmacokinetics of tulathromycin in swine. Part 2: Intra-airways compartments.

@nl

P1433

Q46490969-96EAB939-3A3D-4962-BE53-BB13E4065D80

P1476

Q46490969-9FD9FAE7-6631-4988-A5C8-D37027547036

P2093

Q46490969-1723554F-1EA0-4AC4-B74C-76FDF7BCDD4F

Q46490969-3CD2AA6B-06C4-4087-98A7-623045461F88

Q46490969-61590049-7EA3-4944-9424-408A230CF44C

Q46490969-8446E138-1883-4A9D-99E1-EDD2ADEA481E

Q46490969-B08F481F-8387-4C1C-8DEE-69EC9B1CD0EB

Q46490969-DD3095DD-52F2-4139-A589-859746C4FABF

Q46490969-DDD7A32E-CAC6-4490-8DE5-8FA58BAF4268

Q46490969-E482E32B-88C2-4A37-A316-0ED7A29C1107

Q46490969-EB28B89A-9BDA-43A4-8EB2-7A1422E3E7E0

P2860

Q46490969-068D9041-EE5F-4564-8539-E2C77F8FE0BA

Q46490969-06A1E357-DFE0-4EF1-9F46-AE81EECA2B9C

Q46490969-12A0B274-5AA8-469D-82D1-E0CCA992D07B

Q46490969-16F7E52C-7BE0-422E-B6E9-AC39B4758F35

Q46490969-1D67C3B7-86C4-4AB7-84EC-A49881D8235F

Q46490969-25BC4B62-96A1-441F-82B0-13DA1F16D890

Q46490969-2943A5B8-A9D1-4E64-95BA-B6C5B4267254

Q46490969-2AE4688C-F062-4611-8486-CA29B19DABE7

Q46490969-35F9DBD3-7DCE-4EEE-B02B-3C368519EEEA

Q46490969-3D302672-9498-4F34-89E4-0C5430AA76A9

P304

Q46490969-83A12250-D628-41F2-82EB-3437E6A89EB5

P31

Q46490969-DB31D2A8-38A0-40C4-9687-CB8C3EA76210

P356

Q46490969-1E9E96A3-9BDE-4E81-94F0-602710929AD8

P433

Q46490969-50544CFC-BA8D-43E3-97EC-FE00FDC5DB9B

P478

Q46490969-DFDA8671-1B40-4015-BCE8-0A2A6E807CE4

P577

Q46490969-AD3E3D89-532E-4C44-9232-912777617457

P698

Q46490969-4CB80F5C-38A6-4A20-A271-06C5AE28C25B

P356

P1433

Journal of Veterinary Pharmacology and Therapeutics

P1476

Pulmonary pharmacokinetics of tulathromycin in swine. Part 2: Intra-airways compartments.

@en

P2093

A Fielder

http://www.w3.org/2001/XMLSchema#string

D García-Tapia

http://www.w3.org/2001/XMLSchema#string

J Robinson

http://www.w3.org/2001/XMLSchema#string

M Lucas

http://www.w3.org/2001/XMLSchema#string

N Villarino

http://www.w3.org/2001/XMLSchema#string

S A Brown

http://www.w3.org/2001/XMLSchema#string

S Cox

http://www.w3.org/2001/XMLSchema#string

S Lesman

http://www.w3.org/2001/XMLSchema#string

T Martín-Jiménez

http://www.w3.org/2001/XMLSchema#string

P2860

Uptake, transport, and delivery of antimicrobial agents by human polymorphonuclear neutrophils

In vitro demonstration of transport and delivery of antibiotics by polymorphonuclear leukocytes

Quantitative determination of the macrolide antibiotic tulathromycin in plasma and broncho-alveolar cells of foals using tandem mass spectrometry.

Prophylactic and therapeutic activities of azithromycin in a mouse model of pneumococcal pneumonia.

Intracellular and extracellular penetration of azithromycin into inflammatory and noninflammatory blister fluid.

Penetration of meropenem into pneumonic human lung tissue as measured by in vivo microdialysis.

Long-acting inhaled beta(2)-agonist therapy in asthma.

PET for in vivo pharmacokinetic and pharmacodynamic measurements.

Pulmonary disposition of antimicrobial agents: methodological considerations.

Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue.

P304

340-349

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JVP.12015

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23067107

http://www.w3.org/2001/XMLSchema#string